Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals
Abstract While mRNA vaccines against SARS-CoV-2 are exceedingly effective in preventing symptomatic infection, their immune response features remain to be clarified. In the present prospective study, 225 healthy individuals in Japan, who received two BNT162b2 doses, were enrolled. Correlates of BNT1...
Enregistré dans:
Auteurs principaux: | Kenji Maeda, Masayuki Amano, Yukari Uemura, Kiyoto Tsuchiya, Tomoko Matsushima, Kenta Noda, Yosuke Shimizu, Asuka Fujiwara, Yuki Takamatsu, Yasuko Ichikawa, Hidehiro Nishimura, Mari Kinoshita, Shota Matsumoto, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Shin-ichi Oka, Ayako Mikami, Wataru Sugiura, Toshiyuki Sato, Tomokazu Yoshida, Shinya Shimada, Hiroaki Mitsuya |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/afc0cc4016284319811206f3cc4de9a3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Immunogenicity of a BNT162b2 vaccine booster in health-care workers
par: Esther Saiag, et autres
Publié: (2021) -
What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
par: Nicola Silvestris
Publié: (2021) -
Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum
par: Timothy A. Bates, et autres
Publié: (2021) -
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
par: Yamato Nishiguchi, et autres
Publié: (2021) -
Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccination
par: Akihiro Matsubara, et autres
Publié: (2021)